Inventor
NASVESCHUK CHRISTOPHER G
US52 patents
⚠️ This page may combine multiple inventors who share the name “NASVESCHUK CHRISTOPHER G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
C4 THERAPEUTICS INC
25 patentsUS11185592B2Nov 30, 2021
Spirocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC20 citations93
US11584748B2Feb 21, 2023
Spirocyclic compounds
C4 THERAPEUTICS INC11 citations85
US11524949B2Dec 13, 2022
Degraders and Degrons for targeted protein degradation
C4 THERAPEUTICS INC7 citations85
US11459335B2Oct 4, 2022
N/O-linked Degrons and Degronimers for protein degradation
C4 THERAPEUTICS INC8 citations85
US11691972B2Jul 4, 2023
Compounds for targeted degradation of BRD9
C4 THERAPEUTICS INC5 citations81
US12371442B2Jul 29, 2025
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC1 citations74
US12048747B2Jul 30, 2024
Substituted piperidine Degronimers for Target Protein degradation
C4 THERAPEUTICS INC4 citations74
US11623929B2Apr 11, 2023
Spirocyclic compounds
C4 THERAPEUTICS INC7 citations74
US11992531B2May 28, 2024
C3-carbon linked glutarimide degronimers for target protein degradation
C4 THERAPEUTICS INC3 citations73
US11673902B2Jun 13, 2023
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC3 citations72
US12157735B2Dec 3, 2024
Compounds for targeted degradation of BRD9
C4 THERAPEUTICS INC1 citations69
US12049464B2Jul 30, 2024
Compounds for targeted degradation of BRD9
C4 THERAPEUTICS INC1 citations69
US12570626B2Mar 10, 2026
Degraders and degrons for targeted protein degradation
C4 THERAPEUTICS INC0 citations62
US12486290B2Dec 2, 2025
Isoindolinone and indazole compounds for the degradation of EGFR
C4 THERAPEUTICS INC0 citations62
US12441740B2Oct 14, 2025
N/O-linked degrons and degronimers for protein degradation
C4 THERAPEUTICS INC0 citations62
US12227504B2Feb 18, 2025
Spirocyclic compounds
C4 THERAPEUTICS INC0 citations62
US12180225B2Dec 31, 2024
N/O-linked degrons and degronimers for protein degradation
C4 THERAPEUTICS INC1 citations62
US12076405B2Sep 3, 2024
Heterocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC1 citations62
US12048748B2Jul 30, 2024
Spirocyclic degronimers for target protein degradation
C4 THERAPEUTICS INC1 citations62
US11753397B2Sep 12, 2023
Cereblon binders for the degradation of ikaros
C4 THERAPEUTICS INC1 citations62
US12486253B2Dec 2, 2025
Therapeutics for the degradation of mutant BRAF
C4 THERAPEUTICS INC0 citations59
US12528797B2Jan 20, 2026
Heterocyclic compounds for medical treatment
C4 THERAPEUTICS INC0 citations51
US12559492B2Feb 24, 2026
BRAF degraders
C4 THERAPEUTICS INC0 citations48
US12454521B2Oct 28, 2025
Targeted protein degradation
C4 THERAPEUTICS INC0 citations48
US12421220B2Sep 23, 2025
Bicyclic-substituted glutarimide cereblon binders
C4 THERAPEUTICS INC0 citations47
CONSTELLATION PHARMACEUTICALS INC
11 patentsUS9469646B2Oct 18, 2016
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC21 citations92
US10016405B2Jul 10, 2018
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC3 citations84
US9745305B2Aug 29, 2017
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC11 citations84
US9522920B2Dec 20, 2016
Bromodomain inhibitors and uses thereof
CONSTELLATION PHARMACEUTICALS INC10 citations84
US9409865B2Aug 9, 2016
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC14 citations83
US9371331B2Jun 21, 2016
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC8 citations83
US9206128B2Dec 8, 2015
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC10 citations83
US9051269B2Jun 9, 2015
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC9 citations83
US9980952B2May 29, 2018
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC3 citations73
US9969716B2May 15, 2018
Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC4 citations73
USRE47428EJun 11, 2019
Modulators of methyl modifying enzymes, compositions and uses thereof
CONSTELLATION PHARMACEUTICALS INC0 citations52
GENENTECH INC
9 patentsUS10308614B2Jun 4, 2019
Therapeutic compounds and uses thereof
GENENTECH INC4 citations73
US10239861B2Mar 26, 2019
Therapeutic compounds and uses thereof
GENENTECH INC2 citations72
US10183009B2Jan 22, 2019
Therapeutic compounds and uses thereof
GENENTECH INC3 citations72
US10150767B2Dec 11, 2018
Therapeutic compounds and uses thereof
GENENTECH INC1 citations50
US10358437B2Jul 23, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations41
US10301253B2May 28, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations41
US10202378B2Feb 12, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations41
US10258603B2Apr 16, 2019
Therapeutic compounds and uses thereof
GENENTECH INC0 citations40
US10155764B2Dec 18, 2018
Therapeutic compounds and uses thereof
GENENTECH INC0 citations40
ALBRECHT BRIAN K
2 patentsCONSTELLATION—PHARMACEUTICALS INC
1 patentUNIV COLORADO REGENTS
1 patentLIU XUEDONG
1 patentShowing the top 50 of 52 patents by PatentIndex Score.